RedHill Biopharma Ltd. (RDHL) Earnings Dates & History
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$0.82
-11.51%
Mkt Cap $3.08M
EPS — Estimate vs Actual
Quarterly History
| Q3 2025 Sep 5, 2025 | — | $2.04M | — | — | -$1.15 | — |
| Q4 2024 Oct 3, 2024 | — | — | — | — | $900.00 | — |
| Q3 2024 Aug 29, 2024 | $25.72M | — | — | -$30.00 | -$200.00 | -566.67% |
| Q1 2024 Feb 12, 2024 | $17.55M | — | — | -$0.03 | -$0.20 | -566.67% |
| Q2 2023 Jun 30, 2023 | $2.11M | $1.80M | -15.00% | — | $4.83 | — |
| Q2 2023 Jun 12, 2023 | $3.62M | $3.60M | -0.58% | — | $146.75 | — |
| Q1 2023 Mar 27, 2023 | $17.55M | $12.80M | -27.09% | — | $1.07 | — |
| Q4 2022 Nov 7, 2022 | $21.50M | $17.55M | -18.37% | -$0.30 | -$2.00 | -566.67% |
| Q3 2022 Sep 23, 2022 | $21.50M | $18.35M | -14.67% | — | -$10.04 | — |
| Q2 2022 Jun 23, 2022 | $23.60M | $18.24M | -22.73% | -$4.00 | -$3.00 | +25.00% |
| Q1 2022 Mar 17, 2022 | $24.09M | $22.07M | -8.37% | -$4.00 | -$5.00 | -25.00% |
| Q4 2021 Nov 30, 2021 | $24.52M | $21.61M | -11.87% | -$4.80 | -$4.60 | +4.17% |
| Q3 2021 Aug 26, 2021 | $27.00M | $21.50M | -20.36% | -$4.00 | -$6.20 | -55.00% |
| Q2 2021 May 27, 2021 | $34.31M | $20.57M | -40.04% | -$4.60 | -$5.30 | -15.22% |
| Q1 2021 Mar 18, 2021 | — | $21.46M | — | -$4.50 | -$7.00 | -55.56% |
| Q4 2020 Nov 12, 2020 | — | $20.94M | — | -$2.20 | -$5.00 | -127.27% |
| Q3 2020 Aug 13, 2020 | $3.67M | $20.90M | +470.23% | -$1.40 | -$4.50 | -221.43% |
| Q2 2020 May 27, 2020 | $735.08K | $1.06M | +43.66% | -$3.80 | -$4.90 | -28.95% |
| Q1 2020 Mar 4, 2020 | $724.11K | $1.59M | +119.58% | -$3.20 | -$3.00 | +6.25% |
| Q4 2019 Nov 19, 2019 | $1.60M | $1.40M | -12.50% | -$3.90 | -$3.00 | +23.08% |
| Q3 2019 Jul 23, 2019 | $1.13M | $1.56M | +37.93% | -$3.20 | -$3.80 | -18.75% |
| Q2 2019 May 7, 2019 | $1.34M | $1.74M | +29.63% | -$3.90 | -$3.50 | +10.26% |
| Q1 2019 Feb 26, 2019 | $1.65M | $1.36M | -17.39% | -$3.90 | -$3.40 | +12.82% |
| Q4 2018 Nov 13, 2018 | $2.26M | $2.21M | -2.38% | -$4.00 | -$4.00 | +0.00% |
| Q3 2018 Aug 30, 2018 | $2.03M | $2.35M | +15.79% | -$4.70 | -$5.20 | -10.64% |
| Q2 2018 May 8, 2018 | $2.23M | $2.44M | +9.52% | -$5.70 | -$5.00 | +12.28% |
| Q1 2018 Feb 22, 2018 | $2.33M | $2.00M | -14.29% | -$6.50 | -$5.00 | +23.08% |
| Q4 2017 Nov 13, 2017 | $2.94M | $1.52M | -48.15% | -$7.20 | -$9.00 | -25.00% |
| Q3 2017 Jul 25, 2017 | $457.58K | $483.00K | +5.56% | -$5.80 | -$6.00 | -3.45% |
| Q2 2017 May 3, 2017 | — | — | — | -$6.40 | -$5.00 | +21.88% |
| Q1 2017 Feb 23, 2017 | $110.45K | $100.00K | -9.46% | -$6.30 | -$7.00 | -11.11% |
| Q4 2016 Nov 14, 2016 | — | — | — | -$5.90 | -$7.00 | -18.64% |
| Q3 2016 Jul 26, 2016 | $1.12K | $1.00K | -10.71% | -$6.10 | -$6.00 | +1.64% |
| Q2 2016 Apr 20, 2016 | — | — | — | -$4.80 | -$4.30 | +10.42% |
| Q1 2016 Feb 25, 2016 | — | — | — | -$4.70 | -$5.00 | -6.38% |
| Q4 2015 Nov 9, 2015 | $1.40K | $1.00K | -28.57% | -$5.40 | -$4.00 | +25.93% |
| Q3 2015 Jul 29, 2015 | $789 | $1.00K | +26.74% | -$4.90 | -$6.60 | -34.69% |
| Q2 2015 Apr 30, 2015 | $913 | $1.00K | +9.53% | -$5.60 | -$5.00 | +10.71% |
| Q1 2015 Feb 26, 2015 | $1.00K | $1.00K | +0.00% | -$6.00 | -$6.00 | +0.00% |
| Q4 2014 Nov 10, 2014 | $3.20K | $4.00K | +25.00% | -$6.10 | -$5.00 | +18.03% |
| Q3 2014 Jul 23, 2014 | $2.74K | $4.00K | +46.20% | -$3.80 | -$5.20 | -36.84% |
| Q2 2014 Apr 30, 2014 | $18.20M | $7.00M | -61.50% | -$4.40 | $3.90 | +188.64% |
| Q1 2014 Feb 25, 2014 | $1.00K | $1.00K | +0.00% | -$5.00 | -$5.00 | +0.00% |
| Q4 2013 Nov 12, 2013 | $5.22K | $3.00K | -42.58% | -$6.20 | -$4.30 | +30.65% |
| Q3 2013 Jul 22, 2013 | $6.87K | $4.00K | -41.79% | -$4.40 | -$4.00 | +9.09% |
| Q2 2013 May 2, 2013 | $5.33K | $4.00K | -25.00% | -$4.50 | -$3.00 | +33.33% |
| Q1 2013 Mar 31, 2013 | — | $4.00K | — | — | -$12.98 | — |
| Q3 2012 Sep 30, 2012 | — | $3.00K | — | — | -$14.92 | — |
| Q2 2012 Jun 30, 2012 | — | $5.00K | — | — | -$17.35 | — |
| Q1 2012 Mar 31, 2012 | — | $4.00K | — | — | -$20.90 | — |
| Q4 2011 Dec 31, 2011 | — | $3.00K | — | — | -$20.01 | — |
| Q3 2011 Sep 30, 2011 | — | $11.00K | — | — | -$22.70 | — |